Corporate Banner
Satellite Banner
Molecular & Clinical Diagnostics
Scientific Community
Become a Member | Sign in
Home>News>This Article

Diagnostica Stago Awarded ASCEND Sole Source Agreement with The Premier Healthcare Alliance

Published: Friday, July 12, 2013
Last Updated: Friday, July 12, 2013
Bookmark and Share
Diagnostica Stago, Inc. was recently awarded the sole source contract in addition to renewing a 36-month group purchasing agreement.

The elite award grants special pricing and pre-negotiated terms for Stago's complete coagulation solutions to Premier's ASCEND program members, including high-quality diagnostic instruments and automation-ready reagents.

"Our long-standing partnership with Premier means that our mutual customers benefit from world-class coagulation technologies and expertise, and now Premier's ASCEND members have the added exclusive advantage of pre-negotiated conditions," noted Stephane Zamia, CEO of Diagnostica Stago, Inc. "Ultimately, this means that we can all remain focused on managing and improving healthcare, together."

Stago's focus on coagulation and coagulation technologies includes STA® Hemostasis Analyzers, which range from fully integrated, stand-alone units to manual, benchtop models, depending on the facility's connectivity and throughput needs. Each is capable of performing clotting, chromogenic and immunological assays, and also features patented VDS (Viscosity-based Detection System) electromechanical clot detection technology to eliminate interferences and standardize results across all STA Hemostasis Analyzers. Additionally, a wide range of high-quality, automation-ready reagent test kits are optimized for routine analysis as well as research use. In addition to his leadership in coagulation, Stago is at the forefront of the collaboration with Pharma industry with regards to New oral anticoagulant.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Mathematical Model Forecasts the Path of Breast Cancer
Chances of survival depend on which organs breast cancer tumors colonize first.
Measuring microRNAs in Blood to Speed Cancer Detection
A simple, ultrasensitive microRNA sensor holds promise for the design of new diagnostic strategies and, potentially, for the prognosis and treatment of pancreatic and other cancers.
Biomedical Imaging at One-Thousandth the Cost
Mathematical modeling enables $100 depth sensor to approximate the measurements of a $100,000 piece of lab equipment.
Improving Outcomes for Lung Cancer and Diabetic Patients
Novel technologies have been developed with support from SBRI Healthcare funding.
New Way of Detecting Cancer
A new RNA test of blood platelets can be used to detect, classify and pinpoint the location of cancer by analysing a sample equivalent to one drop of blood.
Rapid, Portable Ebola Diagnostic
Scientists confirmed the efficiency of the novel Ebola detection method in field trials.
New, Better Test for Prostate Cancer
A study from Karolinska Institutet shows that a new test for prostate cancer is better at detecting aggressive cancer than PSA.
Blood Test Picks Out Prostate Cancer Drug Resistance
Scientists have developed a blood test that can identify key mutations driving resistance to a widely used prostate cancer drug, and identify in advance patients who will not respond to treatment.
Antibody Targets Key Cancer Marker
University of Wisconsin-Madison researchers have created a molecular structure that attaches to a molecule on highly aggressive brain cancer and causes tumors to light up in a scanning machine.
Key Piece of MRSA Vaccine Puzzle
New research funded by the Health Research Board and the Wellcome Trust has pinpointed immune cells that could be targeted by an MRSA vaccine.
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos